期刊文献+

超声造影评估宫颈癌化疗疗效 被引量:11

Contrast-enhanced ultrasound in assessing the effect of chemotherapy on cervical cancer
下载PDF
导出
摘要 目的探讨CEUS在宫颈癌化疗疗效评估中的应用价值。方法对42例接受化疗的宫颈癌患者于化疗前及化疗后2周行CEUS检查,应用时间-强度曲线分析病灶造影剂到达时间(AT)、达峰时间(TTP)和峰值强度(PI)。采用妇科检查结合MRI评价化疗疗效,比较不同疗效间CEUS检查结果的差异。结果 29例治疗有效,病灶造影剂AT及TTP较化疗前延长(P均<0.05),PI较化疗前下降(P>0.05);13例治疗无效,病灶造影剂AT及TTP较治疗前缩短(P均>0.05),而PI较治疗前明显增高(P<0.05)。结论应用CEUS技术检测宫颈癌化疗前后肿瘤血流灌注的变化可反映化疗疗效,为疗效评估提供可靠依据。 Objective To observe the value of CEUS in assessing the effect of chemotherapy on cervical cancer. Methods CEUS was performed before and 2 weeks after chemotherapy in 42 patients with cervical cancer. Time-intensity curves were analyzed to get arriving time (AT), time to peak (TTP) and peak intensity (PI) of contrast media. CEUS results of patients with different chemotherapy efficacy assessed by gynaecology examines combined with MRI were compared. Resuits There were 29 cases with response to chemotherapy and 13 without response to chemotherapy. In patients with re sponse to chemotherapy, AT and TTP of contrast dramatically prolonged (P〈0.05), while PI decreased (P〉0.05) after chemotherapy compared with those before chemotherapy. In patients with no response to chemotherapy, AT and TTP of contrast became shorter, while PI increased (P〈0.05) after chemotherapy. Conclusion Perfusion mode of cervical cancer assessed by CEUS can reflect therapeutic effect, which may provide reliable basis for evaluation of chemotherapy.
出处 《中国医学影像技术》 CSCD 北大核心 2013年第6期998-1001,共4页 Chinese Journal of Medical Imaging Technology
基金 国家自然青年科学基金(81201178)
关键词 超声检查 造影剂 时间-强度曲线 子宫颈肿瘤 Ultrasonography Contrast media Time-intensity curve Uterine cervical neoplasms
  • 相关文献

参考文献9

  • 1Shoji T, Kumagai S, Yoshizaki A, et al. Efficacy of neoadjuvantchemotherapy followed by radical hysterectomy in locally ad-vanced non-squamous carcinoma of the uterine cervix: A retro-spective multicenter study of Tohoku Gynecologic Cancer Unit.Eur J Gynaecol Oncol, 2012, 33(4) : 353*357.
  • 2Maneo A, Chiari S, Bonazzi C, et al. Neoadjuvant chemotherapyand conservative surgery for stage IB1 cervical Cancer. GynecolOncol, 2008,111(3):438-443.
  • 3Lassau N, Chami L, Benatsou B, et al. Dynamic contrast-en-hanced ultrasonography (DCE-US) with quantification of tumorperfusion: A new diagnostic tool to evaluate the early effects ofantiangiogenic treatment. Eur Radiol, 2007,17 ( Suppl 6) : F89-F98.
  • 4Quinn MA, Benedet JL, Odicino F, et al. Carcinoma of the cer-vix uteri. FIGO 26th Annual Report on the Results of Treatmentin Gynecological Cancer. Int J Gynecol Obstet, 2006,95 (Suppl1):S43-S103.
  • 5Angioli R, Plotti F, Montera R, et al. Neoadjuvant chemothera-py plus radical surgery followed by chemotherapy in locally ad-vanced cervical Cancer. Gynecol Oncol, 2012, 127(2) :290-296.
  • 6De Giorgi U, Aliberti C, Benea G, et al. Effect of angio.sonogra-phy to monitor response during imatinib treatment in patientswith metastatic gastrointestinal stromal tumors. Clin Cancer Res,2005,11(17):6171-6176.
  • 7Foster FS, Burns PN, Simpson DH, et al. Ultrasound for the vi-sualization and quantification of tumor microcirculation. CancerMetastasis Rev, 2000, 19(.1-2) : 131-138.
  • 8Piscaglia F, Nolse C, Dietrich CF, et al. The EFSUMB guide-lines and recommendations on the clinical practice of contrast en-hanced ultrasound (CEUS) : Update 2011 on non-hepatic applica-tions. Ultraschall Med, 2012, 33( 1) : 33-59.
  • 9Albrecht T, Blomley M, Bolondi L, et al. Guidelines for the useof contrast agents in ultrasound. January 2004. UltraschallMed, 2004,25(4):249-256.

同被引文献88

引证文献11

二级引证文献66

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部